Research and Development

Showing 15 posts of 9573 posts found.

Novartis swine-flu jab effective in single dose

September 3, 2009 Manufacturing and Production, Research and Development, Sales and Marketing Novartis, h1n1

A study of Novartis' pandemic swine-flu jab shows it is potentially protective after just one dose, which could help eke …

Pharmafocus expands into Europe

September 3, 2009 Research and Development, Sales and Marketing Europe

 The September issue of Pharmafocus marks a new stage in the publication’s development with an expanded monthly circulation that takes …

Merck unveils post-merger leadership team

September 3, 2009 Research and Development, Sales and Marketing MA, Merck

The make-up of Merck and Schering-Plough's new corporate entity became clearer this week. Referred to as the 'new Merck' and …

New cancer cases set to hit 17 million by 2020

September 2, 2009 Research and Development, Sales and Marketing Cancer, healthcare

The next ten years will see a 30% leap in the number of new cancer cases across the world, according …

Shire goes for early approval in Gaucher disease

September 1, 2009 Research and Development, Sales and Marketing Gaucher's, Shire

Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …

Pradaxa data boosts Boehringer

September 1, 2009 Research and Development, Sales and Marketing Boehringer, Pradaxa

Boehringer Ingelheim has unveiled new positive data for its blood-thinner Pradaxa, showing it reduces the risk of stroke compared to …

Pfizer agrees price cut in Clinton deal

September 1, 2009 Research and Development, Sales and Marketing HIV, Pfizer, price cuts

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

Indian government accepts pro-patent report

September 1, 2009 Research and Development, Sales and Marketing Asia, India, patents

The government of India has accepted the findings of a report into its patent laws, which recommends maintaining a higher …

Basilea buoyed by sales increase

September 1, 2009 Research and Development, Sales and Marketing Basilea

Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …

Supply chain controls blamed for UK medicines shortage

August 27, 2009 Manufacturing and Production, Research and Development supply chain

Industry supply chain controls in the UK have overwhelmingly made medicines more difficult to source and have put patients risk, …

Americans doubt benefits of health reform

August 27, 2009 Research and Development, Sales and Marketing US, US healthcare, healthcare

Most Americans are satisfied with their existing medical arrangements, according to a survey by Thomson Reuters.The results seem to be …

NICE criticised for rejection of kidney cancer drugs

August 27, 2009 Research and Development, Sales and Marketing Kidney cancer, NICE, Nexavar

Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …

Novartis unveils new lab approach to boost research capacity

August 27, 2009 Research and Development Novartis, Switzerland

Novartis has unveiled a new research approach involving novel lab technology and flexible working, in the hope to speed its …

More evidence of tobacco’s role as drugmaking factory

August 27, 2009 Manufacturing and Production, Research and Development Biodesign Institute

Researchers have successfully engineered tobacco to synthesise the antigens for a vaccine against norovirus, providing further evidence that complex pharmaceuticals …
The Gateway to Local Adoption Series

Latest content